drugset / Trial / NCT01712321

Study of Vilazodone to Treat Social Anxiety Disorder

NCT01712321

RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to determine whether Vilazodone is effective in the treatment of symptoms of Social Anxiety Disorder among adults.

Timeline

Start
2012-10
Primary completion
2014-03
Completion
2014-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Vilazodone Small molecule 20 mg Oral
Subject Vilazodone Small molecule 40 mg Oral

Indications